AFFIMED N V's ticker is AFMD and the CUSIP is N01045108. A total of 94 filers reported holding AFFIMED N V in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $123,024 | -39.9% | 165,000 | 0.0% | 0.00% | – |
| Q4 2022 | $204,600 | -24.5% | 165,000 | +25.6% | 0.00% | – |
| Q3 2022 | $271,000 | -29.4% | 131,400 | -5.2% | 0.00% | – |
| Q2 2022 | $384,000 | -76.7% | 138,600 | -63.3% | 0.00% | -100.0% |
| Q1 2022 | $1,649,000 | +135.6% | 377,300 | +197.3% | 0.00% | – |
| Q4 2021 | $700,000 | -10.7% | 126,900 | 0.0% | 0.00% | – |
| Q3 2021 | $784,000 | -27.3% | 126,900 | 0.0% | 0.00% | – |
| Q2 2021 | $1,079,000 | +7.5% | 126,900 | 0.0% | 0.00% | – |
| Q1 2021 | $1,004,000 | +144.3% | 126,900 | +79.7% | 0.00% | – |
| Q4 2020 | $411,000 | +37.0% | 70,600 | -20.1% | 0.00% | – |
| Q3 2020 | $300,000 | -26.5% | 88,400 | 0.0% | 0.00% | – |
| Q2 2020 | $408,000 | +732.7% | 88,400 | +185.2% | 0.00% | – |
| Q1 2020 | $49,000 | -12.5% | 31,000 | +52.0% | 0.00% | – |
| Q4 2019 | $56,000 | -6.7% | 20,400 | 0.0% | 0.00% | – |
| Q3 2019 | $60,000 | +1.7% | 20,400 | 0.0% | 0.00% | – |
| Q2 2019 | $59,000 | – | 20,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Public Equity Management, LLC | 3,209,013 | $6,578,000 | 0.40% |
| Telemetry Investments, L.L.C. | 367,067 | $752,000 | 0.35% |
| NEA Management Company, LLC | 3,888,888 | $7,972,000 | 0.29% |
| DAFNA Capital Management LLC | 92,500 | $190,000 | 0.14% |
| Tekla Capital Management LLC | 1,405,324 | $2,881,000 | 0.11% |
| Perceptive Advisors | 668,214 | $1,369,000 | 0.07% |
| MUHLENKAMP & CO INC | 72,786 | $149,000 | 0.05% |
| Orbimed Advisors | 1,799,700 | $3,689,000 | 0.04% |
| MOORE CAPITAL MANAGEMENT, LP | 250,000 | $513,000 | 0.02% |
| Baker Brothers Advisors | 400,000 | $820,000 | 0.01% |